Sensus Healthcare Reports Third Quarter 2026 Financial Results and Business Highlights

Joseph Sardano, Chairman and Chief Executive Officer of Sensus Healthcare

“Our third quarter results reflect continued progress in building a broader, more diversified customer base and advancing our business toward sustainable profitability. With dedicated reimbursement codes now in effect, our conversations with physicians are increasingly focused on how to bring SRT into their practices. Our vision is to make SRT a more widely understood and accessible non-invasive treatment option for appropriate patients with non-melanoma skin cancer. We are expanding physician education and patient awareness, including through TreatSkinCancer.com, while pursuing opportunities internationally and developing additional revenue streams tied to system utilization, software and services. The recent sale of our 1,000th SRT system is a milestone I am particularly proud of. We have spent years advancing the technology and growing our installed base. Today, we have a reimbursement framework that we believe can support broader adoption and a more scalable business. Our focus is on converting these opportunities into sales, increasing utilization and building a more diversified, sustainably profitable business.”